| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $309.4M | +19.2% |
| R&D Expense | $39.6M | +9.1% |
| SG&A Expense | $67.7M | +6.2% |
| Operating Income | $38.0M | +92.7% |
| Interest Expense | $40.6M | -8.4% |
| Pre-tax Income | -$10.3M | +58.6% |
| Income Tax | -$2.2M | -1.2% |
| Net Income | -$8.0M | +64.4% |
| EPS (Basic) | -$0.22 | +64.5% |
| EPS (Diluted) | -$0.22 | +64.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.9M | -60.1% |
| Accounts Receivable | $59.9M | +21.2% |
| Inventory | $35.4M | +28.5% |
| Current Assets | $146.2M | -21.0% |
| Total Assets | $684.8M | -6.6% |
| Current Liabilities | $58.6M | +5.6% |
| Long-term Debt | $556.1M | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77.7M | -0.8% |
| Investing Cash Flow | -$72.1M | -43.8% |
| Financing Cash Flow | -$62.7M | -320.8% |
| Total Liabilities |
| $635.4M |
| -8.1% |
| Stockholders' Equity | $49.4M | +18.7% |